Leaflet RYTMONORM 70mg / 20ml solution for injection
Indicated for: cardiac arrhythmias
Route of administration: injectable
Substance: propafenone (antiarrhythmic)
ATC: C01BC03 (Cardiovascular system | Antiarrhythmics, class I and III | Antiarrhythmics, class Ic)
This medicine may cause dizziness or vertigo.
This medicine may have important interactions with other medicines.
This medicine is subject to additional monitoring.
Periodic laboratory tests may be required during treatment.
This medicine may increase the risk of heart rhythm disturbances.
Propafenone is a medication used to treat cardiac arrhythmias, such as atrial fibrillation or ventricular tachycardia. It belongs to the class Ic antiarrhythmics and works by slowing the conduction of electrical impulses in the heart, restoring normal heart rhythm.
The medication is taken orally, usually in tablet form, and should be used as directed by your doctor. It is important to monitor cardiac function during treatment to prevent complications.
Side effects may include dizziness, nausea, constipation, or fatigue. In rare cases, severe adverse effects such as worsening arrhythmias or heart failure may occur, requiring immediate medical attention.
Patients should inform their doctor about any other medications being used or pre-existing conditions, such as heart or liver diseases, to ensure the safe use of propafenone.
General data about RYTMONORM 70mg / 20ml
- Substance: propafenone
- Date of last drug list: 01-08-2023
- Commercial code: W62339001
- Concentration: 70mg / 20ml
- Pharmaceutical form: solution for injection
- Packing volume: 20ml
- Product type: original
- Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).
Pharmaceutical forms available for propafenone
Concentrations available for propafenone
- 150mg
- 300mg
- 35mg/10ml
- 70mg/20ml